1. Home
  2. ELVN vs FLYW Comparison

ELVN vs FLYW Comparison

Compare ELVN & FLYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • FLYW
  • Stock Information
  • Founded
  • ELVN 2016
  • FLYW 2009
  • Country
  • ELVN United States
  • FLYW United States
  • Employees
  • ELVN N/A
  • FLYW N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • FLYW Computer Software: Prepackaged Software
  • Sector
  • ELVN Health Care
  • FLYW Technology
  • Exchange
  • ELVN Nasdaq
  • FLYW Nasdaq
  • Market Cap
  • ELVN 927.8M
  • FLYW 1.1B
  • IPO Year
  • ELVN 2020
  • FLYW 2021
  • Fundamental
  • Price
  • ELVN $17.77
  • FLYW $10.75
  • Analyst Decision
  • ELVN Strong Buy
  • FLYW Buy
  • Analyst Count
  • ELVN 4
  • FLYW 16
  • Target Price
  • ELVN $37.25
  • FLYW $17.71
  • AVG Volume (30 Days)
  • ELVN 361.5K
  • FLYW 2.8M
  • Earning Date
  • ELVN 05-14-2025
  • FLYW 05-06-2025
  • Dividend Yield
  • ELVN N/A
  • FLYW N/A
  • EPS Growth
  • ELVN N/A
  • FLYW N/A
  • EPS
  • ELVN N/A
  • FLYW 0.04
  • Revenue
  • ELVN N/A
  • FLYW $511,493,000.00
  • Revenue This Year
  • ELVN N/A
  • FLYW $18.59
  • Revenue Next Year
  • ELVN N/A
  • FLYW $15.33
  • P/E Ratio
  • ELVN N/A
  • FLYW $299.47
  • Revenue Growth
  • ELVN N/A
  • FLYW 20.97
  • 52 Week Low
  • ELVN $13.30
  • FLYW $8.20
  • 52 Week High
  • ELVN $30.03
  • FLYW $23.40
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.54
  • FLYW 52.38
  • Support Level
  • ELVN $15.81
  • FLYW $10.38
  • Resistance Level
  • ELVN $17.54
  • FLYW $11.33
  • Average True Range (ATR)
  • ELVN 1.30
  • FLYW 0.48
  • MACD
  • ELVN -0.04
  • FLYW -0.10
  • Stochastic Oscillator
  • ELVN 38.06
  • FLYW 30.52

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About FLYW Flywire Corporation Voting

Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary global payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.

Share on Social Networks: